Description

Jemperli is a medication used in the treatment of certain types of cancer, specifically for patients with mismatch repair deficient (dMMR) tumors. It works as a monoclonal antibody that targets specific pathways involved in tumor growth and immune response.

Interpreter Notes

Interpreters should be aware that Jemperli may be referred to in various contexts related to oncology and immunotherapy. It is important to maintain a formal register and avoid colloquial terms. Common variants that may arise include 'Jemperli' used interchangeably with other cancer treatments, but the focus should remain on the specific medication.

Example Sentences

EN: The oncologist recommended Jemperli as a treatment option for the patient's advanced cancer.

ES: El oncólogo recomendó Jemperli como una opción de tratamiento para el cáncer avanzado del paciente.

Common Interpreter Mistakes

Confusing Jemperli with other cancer medications; mispronouncing Jemperli as if it were a common Spanish word; mixing up the indications for Jemperli with those of similar therapies.